ClearPoint Neuro Inc. (CLPT)
NASDAQ
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
8.9552 wk Range
8.27Overview - CLPT - ClearPoint Neuro Inc.
Key Statistics
Valuation
Enterprise Value
313.39M
P/E (Trailing)
-10.13
P/E (Forward)
-7.64
PEG Ratio
-0.12
Price / Sales (TTM)
6.59
Price / Book
25.89
EV / EBITDA
-11.10
Profitability
Gross Margin
61.67%
Profit Margin
-81.75%
Operating Margin
-94.15%
Return on Assets
-24.43%
Return on Equity
-226.52%
Ownership
Shares Outstanding
30.50M
Float
26.28M
Short % of Shares Outstanding
16.14%
Held by Insiders
5.48%
Held by Institutions
52.48%
Price stats
Beta
1.28
50-Day Avg
13.04
200-Day Avg
13.09
Analyst Consensus
2 analysts
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CLPT - ClearPoint Neuro Inc.
Peers - CLPT - ClearPoint Neuro Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - CLPT - ClearPoint Neuro Inc.
About
ClearPoint Neuro Inc. is a medical technology company focused on precision navigation and delivery solutions for complex neurological procedures. The company develops and commercializes platforms used in minimally invasive brain and spine interventions, combining hardware, disposable instruments, and software that…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
